1. Antihyperglycemic and hypoglycemic activity of naturally occurring peptides and protein hydrolysates from easy-to-cook and hard-to-cook beans (Phaseolus vulgaris L.)
- Author
-
Erika Valencia-Mejia, Juan José Acevedo Fernández, Kátia Flávia Fernandes, and Karla A. Batista
- Subjects
Blood Glucose ,Male ,Protein Hydrolysates ,030309 nutrition & dietetics ,Peptide ,Plant Proteins, Dietary ,Hydrolysate ,Mice ,03 medical and health sciences ,0404 agricultural biotechnology ,In vivo ,Animals ,Hypoglycemic Agents ,Glycoside Hydrolase Inhibitors ,Cooking ,Food science ,Protein hydrolysates ,Rats, Wistar ,Phaseolus ,chemistry.chemical_classification ,Mice, Inbred ICR ,0303 health sciences ,biology ,Chemistry ,food and beverages ,04 agricultural and veterinary sciences ,biology.organism_classification ,040401 food science ,In vitro ,Rats ,Hypoglycemic Effects ,Peptides ,Food Science - Abstract
The present study was undertaken to examine the antidiabetic potential of naturally occurring peptides and hydrolysate fractions from easy-to-cook (ETC) and hard-to-cook (HTC) beans. All fractions were tested regarding their in vitro inhibitory activities against α-amylase and α-glucosidase as well as in vivo anti-hyperglycemic and hypoglycemic effects. Results evidenced that the peptide fractions with the lowest molecular weight (3 kDa) have the highest inhibitory activities, and a 16.9%-89.1% inhibition of α-amylase and 34.4%-89.2% inhibition of α-glucosidase were observed. Regarding the antihyperglycemic activity, the fraction ETCNO3-10 showed a better performance than the positive control (acarbose). In addition, results from hypoglycemic activity evidenced that the tested peptide fractions were able to decrease the glucose levels at the same extension of glibenclamide, maintaining a constant basal glucose level without a postprandial hyperglycemia peak. Finally, it is possible to suggest that the naturally occurring peptides and hydrolysate fractions obtained from ETC and HTC common beans could be used in functional food production or pharmaceutical formulations to prevent diabetes.
- Published
- 2019
- Full Text
- View/download PDF